Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925

BACKGROUND: The major limitation to the success of chemotherapy in osteosarcoma is the development of multidrug resistance (MDR). Preventing the emergence of MDR during chemotherapy treatment has been a high priority of clinical and investigational oncology, but it remains an elusive goal. The NSC23...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yang, X, Yang, P, Shen, J, Osaka, E, Choy, E, Cote, G, Harmon, D, Zhang, Z, Mankin, H, Hornicek, F J, Duan, Z
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2014
Sujets:
Translational Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056062/
https://ncbi.nlm.nih.gov/pubmed/24853187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.254
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires